Daniela Zisterer
Overview
Explore the profile of Daniela Zisterer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McCabe N, Stevenson L, Scanlon E, Douglas R, Kennedy S, Keminer O, et al.
Cancers (Basel)
. 2022 Aug;
14(15).
PMID: 35954391
Drug resistance limits the effectiveness of oesophageal adenocarcinoma (OAC) chemotherapies, leading to a poor prognosis for this disease. Elucidation of the underlying resistance mechanisms is key to enabling the identification...
2.
Campiani G, Khan T, Ulivieri C, Staiano L, Papulino C, Magnano S, et al.
Eur J Med Chem
. 2022 Mar;
235:114274.
PMID: 35344902
Autophagy is a lysosome dependent cell survival mechanism and is central to the maintenance of organismal homeostasis in both physiological and pathological situations. Targeting autophagy in cancer therapy attracted considerable...
3.
Saraswati A, Relitti N, Brindisi M, Osko J, Chemi G, Federico S, et al.
ACS Med Chem Lett
. 2020 Nov;
11(11):2268-2276.
PMID: 33214839
Histone deacetylase inhibitors (HDACi) have emerged as promising therapeutics for the treatment of neurodegeneration, cancer, and rare disorders. Herein, we report the development of a series of spiroindoline-based HDAC6 isoform-selective...
4.
Relitti N, Saraswati A, Federico S, Khan T, Brindisi M, Zisterer D, et al.
Curr Top Med Chem
. 2020 Jan;
20(6):433-457.
PMID: 31894749
Telomeres are protective chromosomal ends that shield the chromosomes from DNA damage, exonucleolytic degradation, recombination, and end-to-end fusion. Telomerase is a ribonucleoprotein that adds TTAGGG tandem repeats to the telomeric...
5.
Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, et al.
Med Res Rev
. 2019 Nov;
40(3):1002-1060.
PMID: 31742748
Oral squamous cell carcinomas (OSCC) and esophageal squamous cell carcinomas (ESCC) exhibit a survival rate of less than 60% and 40%, respectively. Late-stage diagnosis and lack of effective treatment strategies...
6.
Saraswati A, Relitti N, Brindisi M, Gemma S, Zisterer D, Butini S, et al.
Drug Discov Today
. 2019 May;
24(7):1370-1388.
PMID: 31136800
Telomerase is a ribonucleic reverse transcriptase enzyme that uses an integral RNA component as a template to add tandem telomeric DNA repeats, TTAGGG, at the 3' end of the chromosomes....
7.
Keely N, Carr M, Yassin B, Ana G, Lloyd D, Zisterer D, et al.
Biomedicines
. 2017 May;
4(3).
PMID: 28536383
Nuclear-receptors are often overexpressed in tumours and can thereby be used as targets when designing novel selective chemotherapeutic agents. To date, many conjugates incorporating an estrogen receptor (ER) ligand have...
8.
Forde J, Maginn E, McNamara G, Martin L, Campiani G, Williams D, et al.
Cancer Biol Ther
. 2010 Dec;
11(4):421-8.
PMID: 21131779
Background: We proposed to investigate the radiosensitizing properties of PBOX-15, a novel microtubule-disrupting agent, in a panel of cancer cell lines. Results: PBOX-15 treatment was associated with significant cell kill...